DA ‐EPOCH‐R for post‐transplant lymphoproliferative disorders

ConclusionsOur findings support several observations in the literature that DA‐EPOCH‐R is efficacious and well‐tolerated for the treatment of advanced, monomorphic PTLD.

Source: European Journal of Haematology - July 13, 2017 Category: Hematology Authors: Christin B. DeStefano, Vera Malkovska, Hind Rafei, Aarthi Shenoy, Kelly Fitzpatrick, Anita Aggarwal, Joseph P. Catlett Tags: CASE REPORT Source Type: research